Not applicableLooking for participantsNCT02026388What this trial is testingRare Kidney Stone Consortium BiobankWho this might be right forPrimary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more Mayo Clinic 2,000
Testing effectiveness (Phase 2)Study completedNCT05001269What this trial is testingNedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal FunctionWho this might be right forPrimary HyperoxaluriaPrimary Hyperoxaluria Type 1Primary Hyperoxaluria Type 2+1 more Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 27
Large-scale testing (Phase 3)Active Not RecruitingNCT04042402What this trial is testingLong Term Extension Study in Patients With Primary HyperoxaluriaWho this might be right forPrimary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)Kidney Diseases+3 more Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 75
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Testing effectiveness (Phase 2)Study completedNCT00254540What this trial is testingStudy of SU011248 in Patients With Advanced Kidney CancerWho this might be right forCarcinoma, Renal Cell Pfizer 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06465472What this trial is testingEvaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3Who this might be right forPrimary Hyperoxaluria Type 1Primary Hyperoxaluria Type 2Primary Hyperoxaluria Type 3 Biocodex 42
Testing effectiveness (Phase 2)Study completedNCT03847909What this trial is testingEvaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2Who this might be right forPrimary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)Kidney Diseases+2 more Novo Nordisk A/S 35